Effect of zincum gloconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults

QJM: An International Journal of Medicine

Volumn 96, Issue 1, 2003, Pages 35-43

  Mossad, S B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; DECONGESTIVE AGENT; GLUCONATE ZINC; NOSE SPRAY; PARACETAMOL; PLACEBO; ZENULLOSE; ZINC ACETATE; ZINC DERIVATIVE; GLUCONIC ACID; ZINC;

ADULT; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRY SKIN; EPISTAXIS; GEL; HEADACHE; HOARSENESS; HUMAN; MAJOR CLINICAL STUDY; NOSE CAVITY; NOSE CONGESTION; NOSE DISEASE; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOVIRUS; SCORING SYSTEM; SCREENING; SIDE EFFECT; SMELLING DISORDER; SNEEZING; SOMNOLENCE; SORE THROAT; TELEPHONE; THROAT DISEASE; TREATMENT OUTCOME; FEMALE; INTRANASAL DRUG ADMINISTRATION; MALE; PATIENT COMPLIANCE; TIME;

ADMINISTRATION, INTRANASAL; ADULT; COMMON COLD; DOUBLE-BLIND METHOD; FEMALE; GELS; GLUCONATES; HUMANS; MALE; PATIENT COMPLIANCE; TIME FACTORS; TREATMENT OUTCOME; ZINC;

EID: 0037259386     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hcg004     Document Type: Article

References (32)

1. Rice DP, Feldman JJ, White KL. The Current Burden of illness in the United States: Occasional Papers of the Institute of Medicine. Washington DC, National Academy of Science, 1976:1.
2. Dingle JH, Badger GF, Jordan WS Jr. Illness in the Home: Study of 25 000 Illnesses in a Group of Cleveland Families. Cleveland, Press of Western Reserve University, 1964.
3. Novick SG, Godfrey JC, Godfrey NJ, Wilder HR. How does zinc modify the common cold? Clinical observations and implications regarding mechanisms of action. Med Hypotheses 1996; 46:295-302.
4. Korant BD, Butterworth BE. Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides. J Virol 1976; 18:298-306.
5. 2+. Biosci Rep 1987; 7:81-91.
6. Harisch G, Kretschmer M. Some aspects of a non-linear effect of zinc ions on the histamine release from rat peritoneal mast cells. Res Commun Chem Pathol Pharmacol 1987; 55:39-46.
7. Berg K, Bolt G, Andersen H, Owen TC. Zinc potentiates the antiviral action of human IFN-alpha tenfold. J Interferon Cytokine Res 2001; 21:471-4.
8. Kelly RW, Abel MH. Copper and zinc inhibit the metabolism of prostaglandin by the human uterus. Biol Reprod 1983; 28:883-9.
9. Eby GA, Davis DR, Halcomb WW. Reduction in duration of common cold by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother 1984; 25:20-4.
10. Al-Nakib W, Higgins PG, Barrow I, Batsone G, Tyrell DA. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. Antimicrob Agents Chemother 1987; 20:893-901.
11. Godfery JC, Conant Sloane B, Smith DS, Turco JH, Meercer N, Godfery NJ. Zinc gluconate and the common cold: a controlled clinical study. J Internat Med Res 1992; 20:234-46.
12. Mossad SB, Macknin ML, Medendorp SV, Mason P. Zinc gluconate lozenges for treating the common cold; a randomized, double-blind, placebo-controlled study. Ann Intern Med 1996; 125:81-8.
13. Prasad AS, Fitzgerald JT, Bao B, Beck FWJ, Chandrasekar PH. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate: a randomized, double blind, placebo-controlled trial. Ann Intern Med 2000; 133:245-52.
14. Hirt M, Nobel S, Ernesto B. Zinc nasal gel for the treatment of common cold symptoms: a double blind, placebo-controlled trial. ENT J 2000; 79:778-82.
15. Farr BM, Conner EM, Betts RF, Oleske J, Minnefor A, Gwaltney JM Jr. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother 1987; 31:1183-7.
16. Douglas RM, Miles HB, Moore BW, Ryan P, Pinnock CB. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infection in Australian adults. Antimicrob Agents Chemother 1987; 31:1263-5.
17. Weismann K, Jackobson JP, Weismann JE, Hammer UM, Nyholm SM, Hansen B, Lomholt KE, Schmidt K. Zinc gluconate lozenges for common cold: a double blind clinical trial. Dan Med Bull 1990; 37:279-81.
18. Smith DS, Helzner EC, Nuttall CE, Collins M, Rofman BA, Ginsberg D, Goswick CB, Magner A. Failure of zinc gluconate in treatment of acute respiratory tract infections. Antimicrob Agents Chemother 1989; 33:646-8.
19. Macknin ML, Piedmonte M, Calendine C, Janosky J, Wald E. Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial. JAMA 1998; 279:1962-7.
20. Turner RB, Cetnarowski WE. Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds. Clin Infect Dis 2000; 31:1202-8.
21. Belongia EA, Berg R, Liu K. A randomized trial of zinc nasal spray for the treatment of upper respiratory illness in adults. Am J Med 2001; 111:103-8.
22. Turner RB. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds. Clin Infect Dis 2001; 33:1865-70.
23. Jackson JL, Peterson C, Lesho E. A meta-analysis of zinc salts lozenges and the common cold. Arch Intern Med 1997; 157:2373-6.
24. Eby GA. Zinc ion availability: the determinant of efficacy in zinc lozenge treatment of common colds. J Antimicrob Chemother 1997; 40:483-93.
25. Gwaltney JM Jr. Rhinovirus infection of the normal human airway. Amer J Respir Crit Care Med 1995; 152:S36-9.
26. Lewis FA, Kenneth ML. Comparison of rhinovirus-sensitive HeLa cells and human embryo fibroblasts for isolation of rhinoviruses from patients with respiratory disease. J Clin Microbiol 1976; 3:528-32.
27. Steininger C, Aberele SW, Popow-Kraupp T. Early detection of acute rhinovirus infections by rapid reverse transcription-PCR assay. J Clin Microbiol 2001; 39:129-33.
28. Jackson G, Dowling H, Spresman I, Boand A. Transmission of the common cold to volunteers under controlled conditions. Arch Intern Med 1958; 101:267-78.
29. Kirkpatrick GL. The common cold. Prim Care 1996; 23:657-75.
30. Noah TL, Henderson FW, Wortman IA, Delvin RB, Handy J, Koren HS, Becker S. Nasal cytokine production in viral acute upper respiratory infections of childhood. J Infect Dis 1995; 171:584-92.
31. Beck FW, Prasad AS, Kaplan J, Fitzgerald JT, Brewer GJ. Changes in cytokines production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol 1997; 272:E1002-7.
32. Desbiens NA. Lessons learned from attempts to establish the blind in placebo-controlled trials of zinc for the common cold. Ann Intern Med 2000; 133:302-3.